• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种可提高输卵管妊娠甲氨蝶呤治疗成功率的新型预测因素。

A novel predict factor that increases the success rate of methotrexate treatment in fallopian tube pregnancy.

作者信息

Lin Qin, Lin Nan, Wang Gongli, Zheng Xuan, Hua Renyi

机构信息

International Peace Maternity and Child Health Hospital of China Welfare Institution (IPMCH), School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory of Embryo Original Diseases, Shanghai Municipal Key Clinical Specialty, Shanghai, China.

出版信息

Ann Transl Med. 2021 Jan;9(2):146. doi: 10.21037/atm-20-7914.

DOI:10.21037/atm-20-7914
PMID:33569448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7867891/
Abstract

BACKGROUND

For stable fallopian tube pregnancy (FTP), methotrexate (MTX) therapy is reported to be as effective as laparoscopy. However, some cases would need further treatment, e.g., another dose of MTX or laparoscopy. This study is to investigate the potential factors during the treatment of FTP that may facilitate the prediction of a successful outcome of MTX therapy.

METHODS

All FTP cases admitted to the International Peace Maternal and Child Health Hospital (IPMCH), Shanghai, China from January 2016 to December 2017 were reviewed. All patients received a single dose of 50 mg/m MTX prior to other treatment. Statistical analysis was performed to determine the correlation between clinical parameters and the success rate of MTX treatment.

RESULTS

The success rate of single-dose MTX was 77.53%. The serum beta-human chorionic gonadotropin (β-hCG) level cut-off value was 452.64 IU/L, with a specificity of 76.7% and sensitivity of 43% [area under the receiver operating characteristic curve (AUC) 0.803; P<0.0001]. In addition, serum β-hCG levels and patient age correlated with the success rate of MTX treatment.

CONCLUSIONS

Lower β-hCG levels led to successful MTX treatment for FTP, with a cutoff value of 452.64 IU/L. Younger patients were more sensitive to MTX treatment. These results may help clinicians when deciding the potential therapy for patients with tubal ectopic pregnancies.

摘要

背景

对于稳定型输卵管妊娠(FTP),据报道甲氨蝶呤(MTX)治疗与腹腔镜检查效果相当。然而,有些病例需要进一步治疗,例如再用一剂MTX或进行腹腔镜检查。本研究旨在调查FTP治疗期间可能有助于预测MTX治疗成功结果的潜在因素。

方法

回顾了2016年1月至2017年12月在中国上海国际和平妇幼保健院收治的所有FTP病例。所有患者在接受其他治疗前均接受了单剂量50mg/m的MTX。进行统计分析以确定临床参数与MTX治疗成功率之间的相关性。

结果

单剂量MTX的成功率为77.53%。血清β-人绒毛膜促性腺激素(β-hCG)水平的截断值为452.64IU/L,特异性为76.7%,敏感性为43%[受试者操作特征曲线(AUC)下面积为0.803;P<0.0001]。此外,血清β-hCG水平和患者年龄与MTX治疗成功率相关。

结论

较低的β-hCG水平导致MTX治疗FTP成功,截断值为452.64IU/L。年轻患者对MTX治疗更敏感。这些结果可能有助于临床医生为输卵管异位妊娠患者决定潜在的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b50f/7867891/faa6c4707baa/atm-09-02-146-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b50f/7867891/e45617828bc3/atm-09-02-146-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b50f/7867891/07cc30c64999/atm-09-02-146-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b50f/7867891/c1567791bce5/atm-09-02-146-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b50f/7867891/bbd009ff4474/atm-09-02-146-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b50f/7867891/9baa5a4a84e9/atm-09-02-146-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b50f/7867891/faa6c4707baa/atm-09-02-146-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b50f/7867891/e45617828bc3/atm-09-02-146-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b50f/7867891/07cc30c64999/atm-09-02-146-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b50f/7867891/c1567791bce5/atm-09-02-146-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b50f/7867891/bbd009ff4474/atm-09-02-146-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b50f/7867891/9baa5a4a84e9/atm-09-02-146-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b50f/7867891/faa6c4707baa/atm-09-02-146-f6.jpg

相似文献

1
A novel predict factor that increases the success rate of methotrexate treatment in fallopian tube pregnancy.一种可提高输卵管妊娠甲氨蝶呤治疗成功率的新型预测因素。
Ann Transl Med. 2021 Jan;9(2):146. doi: 10.21037/atm-20-7914.
2
Predictors and clinical features of methotrexate (MTX) therapy for ectopic pregnancy.甲氨蝶呤(MTX)治疗异位妊娠的预测因素及临床特征。
BMC Pregnancy Childbirth. 2020 Oct 29;20(1):654. doi: 10.1186/s12884-020-03350-8.
3
Cut-off value of initial serum β-hCG level predicting a successful MTX therapy in tubal ectopic pregnancy: a retrospective cohort study.预测甲氨蝶呤治疗输卵管异位妊娠成功的初始血清β-人绒毛膜促性腺激素水平的截断值:一项回顾性队列研究
Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:175-80. doi: 10.1016/j.ejogrb.2014.05.033. Epub 2014 Jun 2.
4
Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy.人绒毛膜促性腺激素的临界值与甲氨蝶呤治疗异位妊娠成功时的疗程数的关系
Fertil Steril. 2009 Oct;92(4):1203-1207. doi: 10.1016/j.fertnstert.2008.07.1775. Epub 2008 Oct 11.
5
Day 1 to day 4 serum hCG change in predicting single-dose methotrexate treatment failure for tubal ectopic pregnancies.第 1 天至第 4 天血清 hCG 变化预测单次甲氨蝶呤治疗输卵管妊娠失败。
Eur J Obstet Gynecol Reprod Biol. 2020 Dec;255:105-110. doi: 10.1016/j.ejogrb.2020.10.036. Epub 2020 Oct 18.
6
Early prediction of the failure of methotrexate treatment by Days 1-4 serum β-hCG change and 48-hour pre-treatment increment inβ-hCG.通过第 1-4 天血清β-hCG 变化和β-hCG 预处理增加 48 小时预测甲氨蝶呤治疗失败。
J Obstet Gynaecol. 2023 Dec;43(1):2183824. doi: 10.1080/01443615.2023.2183824.
7
Routine β-Human Chorionic Gonadotropin Monitoring for Single-Dose Methotrexate Treatment in Ectopic Pregnancy.单剂量甲氨蝶呤治疗异位妊娠时的常规β-人绒毛膜促性腺激素监测
J Minim Invasive Gynecol. 2017 Nov-Dec;24(7):1195-1199. doi: 10.1016/j.jmig.2017.07.025. Epub 2017 Aug 8.
8
Predictors of Successful Medical Management With Methotrexate in Unruptured Tubal Ectopic Pregnancy.甲氨蝶呤药物治疗未破裂输卵管异位妊娠成功的预测因素
Cureus. 2022 Nov 26;14(11):e31923. doi: 10.7759/cureus.31923. eCollection 2022 Nov.
9
Human chorionic gonadotropin value and its change prior to methotrexate treatment can predict the prognosis in ectopic tubal pregnancies.甲氨蝶呤治疗前的人绒毛膜促性腺激素值及其变化可预测输卵管异位妊娠的预后。
Reprod Med Biol. 2018 Oct 11;18(1):51-56. doi: 10.1002/rmb2.12247. eCollection 2019 Jan.
10
Daily variations and levels of human chorionic gonadotropin before methotrexate treatment as predictors of treatment success.甲氨蝶呤治疗前人绒毛膜促性腺激素的日变化和水平可预测治疗成功。
J Obstet Gynaecol Res. 2022 Dec;48(12):3128-3136. doi: 10.1111/jog.15413. Epub 2022 Sep 2.

引用本文的文献

1
Do the change in β-hCG values between the 0th and 4th days in tubal ectopic pregnancy treatment with a single-dose methotrexate (MTX) protocol predict the need for a second dose of MTX?单次甲氨蝶呤(MTX)方案治疗输卵管妊娠时第 0 天至第 4 天β-hCG 值的变化是否预示着需要第二剂 MTX?
Arch Gynecol Obstet. 2024 Jun;309(6):2585-2590. doi: 10.1007/s00404-023-07116-3. Epub 2023 Jul 26.
2
Clinical Presentation as a Predictor of the Response to Methotrexate Therapy in Patients with Ectopic Pregnancy.临床表现对异位妊娠患者接受甲氨蝶呤治疗反应的预测作用。
J Pregnancy. 2022 Nov 28;2022:5778321. doi: 10.1155/2022/5778321. eCollection 2022.

本文引用的文献

1
ACOG Practice Bulletin No. 191 Summary: Tubal Ectopic Pregnancy.ACOG 实践公告第 191 号摘要:输卵管妊娠。
Obstet Gynecol. 2018 Feb;131(2):409-411. doi: 10.1097/AOG.0000000000002499.
2
Multiple-dose and double-dose versus single-dose administration of methotrexate for the treatment of ectopic pregnancy: a systematic review and meta-analysis.甲氨蝶呤多剂量、双倍剂量与单剂量给药治疗异位妊娠的系统评价与荟萃分析
Reprod Biomed Online. 2017 Apr;34(4):383-391. doi: 10.1016/j.rbmo.2017.01.004. Epub 2017 Jan 17.
3
Diagnosis and Management of Ectopic Pregnancy: Green-top Guideline No. 21.
异位妊娠的诊断与管理:第21号绿帽指南
BJOG. 2016 Dec;123(13):e15-e55. doi: 10.1111/1471-0528.14189. Epub 2016 Nov 3.
4
Correlation of the volume of ectopic pregnancy and MTX therapy outcome: a retrospective cohort study.异位妊娠体积与甲氨蝶呤治疗效果的相关性:一项回顾性队列研究。
Eur J Obstet Gynecol Reprod Biol. 2015 Jan;184:108-11. doi: 10.1016/j.ejogrb.2014.09.038. Epub 2014 Oct 19.
5
Cut-off value of initial serum β-hCG level predicting a successful MTX therapy in tubal ectopic pregnancy: a retrospective cohort study.预测甲氨蝶呤治疗输卵管异位妊娠成功的初始血清β-人绒毛膜促性腺激素水平的截断值:一项回顾性队列研究
Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:175-80. doi: 10.1016/j.ejogrb.2014.05.033. Epub 2014 Jun 2.
6
Role of initial and day 4 human chorionic gonadotropin levels in predicting the outcome of single-dose methotrexate treatment in women with tubal ectopic pregnancy.单次甲氨蝶呤治疗输卵管妊娠中初始和第 4 天人绒毛膜促性腺激素水平对结局的预测作用。
Arch Gynecol Obstet. 2013 Nov;288(5):1149-52. doi: 10.1007/s00404-013-2879-8. Epub 2013 May 12.
7
"Watchful waiting" in ectopic pregnancies: a balance between reduced success rates and less methotrexate.期待疗法治疗异位妊娠:降低成功率与减少甲氨蝶呤使用之间的平衡。
Fertil Steril. 2011 Mar 1;95(3):1159-60. doi: 10.1016/j.fertnstert.2010.10.014. Epub 2010 Nov 10.
8
The efficacy of multiple-dose methotrexate treatment for unruptured tubal ectopic pregnancy and conversion rate to surgery: a study on 294 cases.多剂量甲氨蝶呤治疗未破裂型输卵管妊娠的疗效及手术转化率:294 例研究。
Fertil Steril. 2010 May 1;93(7):2415-7. doi: 10.1016/j.fertnstert.2009.09.014. Epub 2010 Feb 4.
9
Tubal ectopic pregnancy: diagnosis and management.输卵管异位妊娠:诊断与处理
Arch Gynecol Obstet. 2009 Apr;279(4):443-53. doi: 10.1007/s00404-008-0731-3. Epub 2008 Jul 30.
10
Ectopic pregnancy rate and treatment utilization in a large managed care organization.大型管理式医疗组织中的异位妊娠率及治疗利用情况
Obstet Gynecol. 2005 May;105(5 Pt 1):1052-7. doi: 10.1097/01.AOG.0000158860.26939.2d.